Recursion Pharmaceuticals (RXRX) reached $3.11 at the closing of the latest trading day, reflecting a +1.63% change compared to its last close.

Many have now seen the masses march in Minneapolis calling for an end to U.S. Immigration and Customs Enforcement operations. But some are choosing a silent expression of protest with Scandinavian ...

Forbes contributors publish independent expert analyses and insights. Tiana Randall is a writer whose work intersects style and sports. The hesitation was understandable. We were already drowning in ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Agent workflows make transport a first-order ...

You don't call RLM tools directly. You ask Claude to analyze large files, and Claude uses RLM behind the scenes. With these in place, Claude will autonomously detect when to use RLM instead of reading ...

According to God of Prompt on Twitter, the implementation of verification loops in AI models—where the system recursively checks its answers using different reasoning modes such as backward ...

Health Discovery Corp. company and executive profile by Barron's. View the latest HDVY company infomation and executive bios.

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.